Paasa Logo
iHuman Inc. logo
IHNYSEMarket closedOpens 9:30am ET

iHuman Inc.

$1.17Last updated
+$0.02 (1.74%)Past day
Timezone

iHuman Inc. (NYSE: IH) is trading at $1.17, about ₹112 at today's USD/INR rate, as of 29 Sep 2026, 3:59 PM ET, up 1.74% today. Indian residents can buy iHuman from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$1.14
Previous close:$1.15
Volume:1.23K

Today's low

$1.14

Today's high

$1.17

52 week low

$1.11

52 week high

$3.09

IH opened at $1.14, closed previously at $1.15, and has traded between $1.11 and $3.09 over the past 52 weeks.

About

Operating within the People's Republic of China, iHuman Inc. specializes in delivering educational resources aimed at fostering cognitive growth. Their offerings reach a broad audience, encompassing individual consumers, early learning institutions, and wholesale distributors. A significant portion of their portfolio consists of interactive and self-guided digital applications. These include popular titles such as iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, and iHuman Readers. Beyond digital platforms, iHuman Inc. also furnishes a diverse array of physical educational content, ranging from books and interactive tools to smart devices. These resources are specifically designed to cultivate essential childhood skills, such as verbal communication, analytical reasoning, autonomous reading, and creative expression. Established in 1996, the company maintains its headquarters in Beijing, located within the People's Republic of China.

Country
CN
CEO
Peng Dai
Exchange listed on
NYSE
Industry
Education & Training Services
Base currency
USD
Full Time Employees
558
Sector
Consumer Defensive
IPO date
09/10/2020

Key statistics

Avg. volume

10.69K

Market cap

$11.98M

P/E Ratio

1.10

Price-to-sales ratio

0.10

Enterprise value

-CN¥989.53M

Free cash flow yield

29.91%

Debt-to-equity ratio

0.01

Return on equity

9.58%

ROIC

6.21%

Beta

0.13

Dividend yield

7.26%

Last dividend

$0.09

Financial overview

Revenue

CN¥807.02M

Earnings per share

CN¥9.10

Free cash flow

CN¥45.15M

Net profit margin

9.42%

Gross margin

67.49%

EBITDA

CN¥109.54M

Revenue growth

-12.49%

Similar securities

This is not an investment recommendation

How to buy iHuman from India

Indian residents can buy iHuman shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for iHuman and place an order

    Find iHuman by name or by its ticker, IH, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. iHuman trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your iHuman position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in iHuman from India

Trading and taxes when buying iHuman from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. iHuman’s current yield is 7.26%.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy iHuman stock?

Yes. iHuman (IH) has been listed on the New York Stock Exchange since 2020, in the Education & Training Services industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one iHuman share cost in rupees?

One iHuman share is $1.17 — about ₹112 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the iHuman price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying iHuman from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of iHuman?

Yes. One iHuman share is $1.17, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in iHuman.

How are gains on iHuman shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the iHuman price. Paasa issues a capital-gains statement for your return.

Does iHuman pay a dividend, and how is it taxed in India?

Yes. iHuman pays a dividend and the current yield is 7.26%; the last declared dividend was $0.09 per share, about ₹8.17. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade iHuman from India?

The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is iHuman a United States company, and does that change how it is taxed?

iHuman trades on the New York Stock Exchange in US dollars, but the company is domiciled in China. iHuman trades as an American Depositary Receipt rather than an ordinary share. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.

Do I have to declare iHuman shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your iHuman holding, its cost and its closing value.

How do I sell iHuman and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.